Van Lanschot Kempen Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
7,094
+1,627
| +30% | +$854K | 0.04% | 210 |
|
|
2025
Q1 | $3.47M | Buy |
5,467
+149
| +3% | +$94.5K | 0.04% | 198 |
|
|
2024
Q4 | $3.79M | Sell |
5,318
-954
| -15% | -$680K | 0.04% | 194 |
|
|
2024
Q3 | $6.59M | Sell |
6,272
-1,313
| -17% | -$1.38M | 0.07% | 152 |
|
|
2024
Q2 | $7.97M | Buy |
7,585
+958
| +14% | +$1.01M | 0.09% | 142 |
|
|
2024
Q1 | $6.38M | Buy |
6,627
+1,520
| +30% | +$1.46M | 0.08% | 148 |
|
|
2023
Q4 | $4.49M | Buy |
5,107
+272
| +6% | +$239K | 0.06% | 152 |
|
|
2023
Q3 | $3.98M | Buy |
4,835
+403
| +9% | +$332K | 0.07% | 132 |
|
|
2023
Q2 | $3.18M | Buy |
4,432
+136
| +3% | +$97.7K | 0.06% | 146 |
|
|
2023
Q1 | $3.53M | Buy |
4,296
+240
| +6% | +$197K | 0.07% | 141 |
|
|
2022
Q4 | $2.93M | Buy |
4,056
+410
| +11% | +$296K | 0.09% | 142 |
|
|
2022
Q3 | $2.51M | Sell |
3,646
-568
| -13% | -$391K | 0.1% | 132 |
|
|
2022
Q2 | $2.49M | Buy |
4,214
+170
| +4% | +$100K | 0.09% | 132 |
|
|
2022
Q1 | $2.82M | Buy |
+4,044
| New | +$2.82M | 0.09% | 129 |
|